APA-viite

Harrold, L. R., Reed, G. W., Magner, R., Shewade, A., John, A., Greenberg, J. D., & Kremer, J. M. (2015). Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry. Arthritis Res Ther.

Chicago-tyylinen lähdeviittaus

Harrold, Leslie R., George W. Reed, Robert Magner, Ashwini Shewade, Ani John, Jeffrey D. Greenberg, ja Joel M. Kremer. "Comparative Effectiveness and Safety of Rituximab Versus Subsequent Anti–tumor Necrosis Factor Therapy in Patients With Rheumatoid Arthritis With Prior Exposure to Anti–tumor Necrosis Factor Therapies in the United States Corrona Registry." Arthritis Res Ther 2015.

MLA-viite

Harrold, Leslie R., et al. "Comparative Effectiveness and Safety of Rituximab Versus Subsequent Anti–tumor Necrosis Factor Therapy in Patients With Rheumatoid Arthritis With Prior Exposure to Anti–tumor Necrosis Factor Therapies in the United States Corrona Registry." Arthritis Res Ther 2015.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.